Exogenous supplement of N-acetylneuraminic acid improves macrophage reverse cholesterol transport in apolipoprotein E-deficient mice View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-01-24

AUTHORS

Pengbo Hou, Shumei Hu, Jin Wang, Zixun Yang, Jiayu Yin, Guanghai Zhou, Shoudong Guo

ABSTRACT

BACKGROUND: N-acetylneuraminic acid (NANA) is the major form of sialic acid in mammals, and the plasma NANA level is increased in patients with cardiovascular diseases. Exogenous supplement of NANA has been demonstrated to reduce hyperlipidaemia and the formation of atherosclerotic lesions; however, the underlying mechanisms have not yet been clarified. The aim of this study is to investigate whether exogenous supplement of NANA improves reverse cholesterol transprot (RCT) in vivo. METHODS: Apolipoprotein E-deficient mice fed a high-fat diet were used to investigate the effect of NANA on RCT by [3H]-cholesterol-loaded macrophages, and the underlying mechanism was further investigated by various molecular techniques using fenofibrate as a positive control. RESULTS: Our novel results demonstrated that exogenous supplement of NANA significantly improved [3H]-cholesterol transfer from [3H]-cholesterol-loaded macrophages to the plasma (an increase of > 42.9%), liver (an increase of 35.8%), and finally to the feces (an increase of 50.4% from 0 to 24 h) for excretion in apolipoprotein E-deficient mice fed a high-fat diet. In addition, NANA up regulated the protein expression of ATP-binding cassette (ABC) G1 and peroxisome proliferator-activated receptor α (PPARα), but not the protein expression of ABCA1and scavenger receptor B type 1 in the liver. Therefore, the underlying mechanism of NANA in improving RCT may be partially due to the elevated protein levels of PPARα and ABCG1. CONCLUSION: Exogenous supplement of NANA improves RCT in apolipoprotein E-deficient mice fed a high-fat diet mainly by improving the protein expression of PPARα and ABCG1. These results are helpful in explaining the lipid-lowering effect of NANA. More... »

PAGES

24

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12944-019-0971-1

DOI

http://dx.doi.org/10.1186/s12944-019-0971-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111637530

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30678697


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1101", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biochemistry and Metabolomics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apolipoproteins E", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diet, High-Fat", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dietary Supplements", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipid Metabolism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Macrophages", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "N-Acetylneuraminic Acid", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China", 
          "id": "http://www.grid.ac/institutes/grid.268079.2", 
          "name": [
            "Research Center on Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin, 150076 China", 
            "Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hou", 
        "givenName": "Pengbo", 
        "id": "sg:person.016074614653.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016074614653.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China", 
          "id": "http://www.grid.ac/institutes/grid.268079.2", 
          "name": [
            "Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hu", 
        "givenName": "Shumei", 
        "id": "sg:person.010264243767.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010264243767.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China", 
          "id": "http://www.grid.ac/institutes/grid.268079.2", 
          "name": [
            "Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Jin", 
        "id": "sg:person.011657204767.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011657204767.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China", 
          "id": "http://www.grid.ac/institutes/grid.268079.2", 
          "name": [
            "Research Center on Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin, 150076 China", 
            "Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "Zixun", 
        "id": "sg:person.013252145767.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013252145767.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China", 
          "id": "http://www.grid.ac/institutes/grid.268079.2", 
          "name": [
            "Research Center on Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin, 150076 China", 
            "Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yin", 
        "givenName": "Jiayu", 
        "id": "sg:person.014645106767.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014645106767.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Taishan Medical University, Taian, 271000 China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Taishan Medical University, Taian, 271000 China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "Guanghai", 
        "id": "sg:person.010676021371.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010676021371.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Taishan Medical University, Taian, 271000 China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Research Center on Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin, 150076 China", 
            "Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China", 
            "Taishan Medical University, Taian, 271000 China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guo", 
        "givenName": "Shoudong", 
        "id": "sg:person.01053105430.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053105430.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nm.1956", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013401823", 
          "https://doi.org/10.1038/nm.1956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12944-016-0393-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040094135", 
          "https://doi.org/10.1186/s12944-016-0393-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrcardio.2010.222", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003407437", 
          "https://doi.org/10.1038/nrcardio.2010.222"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-01-24", 
    "datePublishedReg": "2019-01-24", 
    "description": "BACKGROUND: N-acetylneuraminic acid (NANA) is the major form of sialic acid in mammals, and the plasma NANA level is increased in patients with cardiovascular diseases. Exogenous supplement of NANA has been demonstrated to reduce hyperlipidaemia and the formation of atherosclerotic lesions; however, the underlying mechanisms have not yet been clarified. The aim of this study is to investigate whether exogenous supplement of NANA improves reverse cholesterol transprot (RCT) in vivo.\nMETHODS: Apolipoprotein E-deficient mice fed a high-fat diet were used to investigate the effect of NANA on RCT by [3H]-cholesterol-loaded macrophages, and the underlying mechanism was further investigated by various molecular techniques using fenofibrate as a positive control.\nRESULTS: Our novel results demonstrated that exogenous supplement of NANA significantly improved [3H]-cholesterol transfer from [3H]-cholesterol-loaded macrophages to the plasma (an increase of >\u200942.9%), liver (an increase of 35.8%), and finally to the feces (an increase of 50.4% from 0 to 24\u2009h) for excretion in apolipoprotein E-deficient mice fed a high-fat diet. In addition, NANA up regulated the protein expression of ATP-binding cassette (ABC) G1 and peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1), but not the protein expression of ABCA1and scavenger receptor B type 1 in the liver. Therefore, the underlying mechanism of NANA in improving RCT may be partially due to the elevated protein levels of PPAR\u03b1 and ABCG1.\nCONCLUSION: Exogenous supplement of NANA improves RCT in apolipoprotein E-deficient mice fed a high-fat diet mainly by improving the protein expression of PPAR\u03b1 and ABCG1. These results are helpful in explaining the lipid-lowering effect of NANA.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12944-019-0971-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.8368373", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.7190343", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1031029", 
        "issn": [
          "1476-511X"
        ], 
        "name": "Lipids in Health and Disease", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "keywords": [
      "high-fat diet", 
      "deficient mice", 
      "apolipoprotein E", 
      "cholesterol-loaded macrophages", 
      "exogenous supplement", 
      "protein expression", 
      "scavenger receptor B type 1", 
      "macrophage reverse cholesterol transport", 
      "peroxisome proliferator-activated receptor \u03b1", 
      "proliferator-activated receptor \u03b1", 
      "lipid-lowering effects", 
      "reverse cholesterol transport", 
      "underlying mechanism", 
      "elevated protein levels", 
      "NANA levels", 
      "cassette G1", 
      "cardiovascular disease", 
      "atherosclerotic lesions", 
      "receptor \u03b1", 
      "type 1", 
      "RCTs", 
      "cholesterol transport", 
      "mice", 
      "acetylneuraminic acid", 
      "protein levels", 
      "positive control", 
      "diet", 
      "PPAR\u03b1", 
      "sialic acid", 
      "ABCG1", 
      "liver", 
      "supplements", 
      "macrophages", 
      "cholesterol transfer", 
      "expression", 
      "hyperlipidaemia", 
      "major form", 
      "patients", 
      "nana", 
      "molecular techniques", 
      "lesions", 
      "fenofibrate", 
      "excretion", 
      "disease", 
      "levels", 
      "vivo", 
      "feces", 
      "acid", 
      "mechanism", 
      "effect", 
      "aim", 
      "G1", 
      "plasma", 
      "ATP", 
      "control", 
      "study", 
      "results", 
      "mammals", 
      "addition", 
      "novel results", 
      "form", 
      "technique", 
      "formation", 
      "transport", 
      "transfer", 
      "plasma NANA level", 
      "cholesterol transprot", 
      "transprot", 
      "effect of NANA", 
      "receptor B type 1", 
      "B type 1"
    ], 
    "name": "Exogenous supplement of N-acetylneuraminic acid improves macrophage reverse cholesterol transport in apolipoprotein E-deficient mice", 
    "pagination": "24", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111637530"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12944-019-0971-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30678697"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12944-019-0971-1", 
      "https://app.dimensions.ai/details/publication/pub.1111637530"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_806.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12944-019-0971-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12944-019-0971-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12944-019-0971-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12944-019-0971-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12944-019-0971-1'


 

This table displays all metadata directly associated to this object as RDF triples.

244 TRIPLES      22 PREDICATES      112 URIs      101 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12944-019-0971-1 schema:about N20339a0c49d84904a89b228a9e8af496
2 N282a98c4f28e4723a44ff83ef1675dc2
3 N339d1851a90f4c918ec6d92c42817db3
4 N500728d969db480ca9b647cf919d9b4d
5 N5fa57fd427694e88b399710ab73e598c
6 N7c9692a1ff494448b37e6ae6645ba6dc
7 N8b9f8f677bd745898e46939c62017c98
8 N8c6ae8b65ec54b298f341eac5042ec9f
9 Nad02e44152214e3a8cecff6ed2bacf08
10 Ncd7811c1a96f4ffbbce517c9ebd3be5a
11 Nd64d3cdf0f8f433d9246ce72c6331701
12 Ne22fae1dfa804f1b85d35fbfa5daf3e1
13 anzsrc-for:11
14 anzsrc-for:1101
15 schema:author Na4d8bd45c31443d6b9becb4eba4ace6e
16 schema:citation sg:pub.10.1038/nm.1956
17 sg:pub.10.1038/nrcardio.2010.222
18 sg:pub.10.1186/s12944-016-0393-2
19 schema:datePublished 2019-01-24
20 schema:datePublishedReg 2019-01-24
21 schema:description BACKGROUND: N-acetylneuraminic acid (NANA) is the major form of sialic acid in mammals, and the plasma NANA level is increased in patients with cardiovascular diseases. Exogenous supplement of NANA has been demonstrated to reduce hyperlipidaemia and the formation of atherosclerotic lesions; however, the underlying mechanisms have not yet been clarified. The aim of this study is to investigate whether exogenous supplement of NANA improves reverse cholesterol transprot (RCT) in vivo. METHODS: Apolipoprotein E-deficient mice fed a high-fat diet were used to investigate the effect of NANA on RCT by [<sup>3</sup>H]-cholesterol-loaded macrophages, and the underlying mechanism was further investigated by various molecular techniques using fenofibrate as a positive control. RESULTS: Our novel results demonstrated that exogenous supplement of NANA significantly improved [<sup>3</sup>H]-cholesterol transfer from [<sup>3</sup>H]-cholesterol-loaded macrophages to the plasma (an increase of &gt; 42.9%), liver (an increase of 35.8%), and finally to the feces (an increase of 50.4% from 0 to 24 h) for excretion in apolipoprotein E-deficient mice fed a high-fat diet. In addition, NANA up regulated the protein expression of ATP-binding cassette (ABC) G1 and peroxisome proliferator-activated receptor α (PPARα), but not the protein expression of ABCA1and scavenger receptor B type 1 in the liver. Therefore, the underlying mechanism of NANA in improving RCT may be partially due to the elevated protein levels of PPARα and ABCG1. CONCLUSION: Exogenous supplement of NANA improves RCT in apolipoprotein E-deficient mice fed a high-fat diet mainly by improving the protein expression of PPARα and ABCG1. These results are helpful in explaining the lipid-lowering effect of NANA.
22 schema:genre article
23 schema:inLanguage en
24 schema:isAccessibleForFree true
25 schema:isPartOf N5132835d999b46dcbd01c78c0cbed561
26 N56d9fd2bb3544707a0254320cfc6e6e4
27 sg:journal.1031029
28 schema:keywords ABCG1
29 ATP
30 B type 1
31 G1
32 NANA levels
33 PPARα
34 RCTs
35 acetylneuraminic acid
36 acid
37 addition
38 aim
39 apolipoprotein E
40 atherosclerotic lesions
41 cardiovascular disease
42 cassette G1
43 cholesterol transfer
44 cholesterol transport
45 cholesterol transprot
46 cholesterol-loaded macrophages
47 control
48 deficient mice
49 diet
50 disease
51 effect
52 effect of NANA
53 elevated protein levels
54 excretion
55 exogenous supplement
56 expression
57 feces
58 fenofibrate
59 form
60 formation
61 high-fat diet
62 hyperlipidaemia
63 lesions
64 levels
65 lipid-lowering effects
66 liver
67 macrophage reverse cholesterol transport
68 macrophages
69 major form
70 mammals
71 mechanism
72 mice
73 molecular techniques
74 nana
75 novel results
76 patients
77 peroxisome proliferator-activated receptor α
78 plasma
79 plasma NANA level
80 positive control
81 proliferator-activated receptor α
82 protein expression
83 protein levels
84 receptor B type 1
85 receptor α
86 results
87 reverse cholesterol transport
88 scavenger receptor B type 1
89 sialic acid
90 study
91 supplements
92 technique
93 transfer
94 transport
95 transprot
96 type 1
97 underlying mechanism
98 vivo
99 schema:name Exogenous supplement of N-acetylneuraminic acid improves macrophage reverse cholesterol transport in apolipoprotein E-deficient mice
100 schema:pagination 24
101 schema:productId N29eff02364e547a8a15a1ba59b2c25e7
102 N4a43c0f065844b31ad690dd83b76426d
103 N8b4d2bb203094d91b892a4208e336f79
104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111637530
105 https://doi.org/10.1186/s12944-019-0971-1
106 schema:sdDatePublished 2021-12-01T19:44
107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
108 schema:sdPublisher N49e2ab4a868d4f77a620ff452436ef07
109 schema:url https://doi.org/10.1186/s12944-019-0971-1
110 sgo:license sg:explorer/license/
111 sgo:sdDataset articles
112 rdf:type schema:ScholarlyArticle
113 N07a1a52659804bfaa80de1cd2f6e809b rdf:first sg:person.01053105430.44
114 rdf:rest rdf:nil
115 N140207dfd6a54a738df58456d174367c rdf:first sg:person.013252145767.19
116 rdf:rest N6d9a7159b8914c41b3821288072dd0d2
117 N20339a0c49d84904a89b228a9e8af496 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Liver
119 rdf:type schema:DefinedTerm
120 N282a98c4f28e4723a44ff83ef1675dc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Lipid Metabolism
122 rdf:type schema:DefinedTerm
123 N29eff02364e547a8a15a1ba59b2c25e7 schema:name doi
124 schema:value 10.1186/s12944-019-0971-1
125 rdf:type schema:PropertyValue
126 N339d1851a90f4c918ec6d92c42817db3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Cholesterol
128 rdf:type schema:DefinedTerm
129 N49e2ab4a868d4f77a620ff452436ef07 schema:name Springer Nature - SN SciGraph project
130 rdf:type schema:Organization
131 N4a43c0f065844b31ad690dd83b76426d schema:name dimensions_id
132 schema:value pub.1111637530
133 rdf:type schema:PropertyValue
134 N4d12dce4fa57406d92b93455efaafa40 rdf:first sg:person.011657204767.66
135 rdf:rest N140207dfd6a54a738df58456d174367c
136 N500728d969db480ca9b647cf919d9b4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Apolipoproteins E
138 rdf:type schema:DefinedTerm
139 N5132835d999b46dcbd01c78c0cbed561 schema:issueNumber 1
140 rdf:type schema:PublicationIssue
141 N56d9fd2bb3544707a0254320cfc6e6e4 schema:volumeNumber 18
142 rdf:type schema:PublicationVolume
143 N5fa57fd427694e88b399710ab73e598c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Animals
145 rdf:type schema:DefinedTerm
146 N6d9a7159b8914c41b3821288072dd0d2 rdf:first sg:person.014645106767.17
147 rdf:rest N7c117b71653b466097f083c6c1aba2fc
148 N7c117b71653b466097f083c6c1aba2fc rdf:first sg:person.010676021371.03
149 rdf:rest N07a1a52659804bfaa80de1cd2f6e809b
150 N7c9692a1ff494448b37e6ae6645ba6dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Dietary Supplements
152 rdf:type schema:DefinedTerm
153 N8b4d2bb203094d91b892a4208e336f79 schema:name pubmed_id
154 schema:value 30678697
155 rdf:type schema:PropertyValue
156 N8b9f8f677bd745898e46939c62017c98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Macrophages
158 rdf:type schema:DefinedTerm
159 N8c6ae8b65ec54b298f341eac5042ec9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Mice
161 rdf:type schema:DefinedTerm
162 Na4d8bd45c31443d6b9becb4eba4ace6e rdf:first sg:person.016074614653.96
163 rdf:rest Nf24153630d474f27be554aa42c92380e
164 Nad02e44152214e3a8cecff6ed2bacf08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Diet, High-Fat
166 rdf:type schema:DefinedTerm
167 Ncd7811c1a96f4ffbbce517c9ebd3be5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Humans
169 rdf:type schema:DefinedTerm
170 Nd64d3cdf0f8f433d9246ce72c6331701 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name N-Acetylneuraminic Acid
172 rdf:type schema:DefinedTerm
173 Ne22fae1dfa804f1b85d35fbfa5daf3e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Cardiovascular Diseases
175 rdf:type schema:DefinedTerm
176 Nf24153630d474f27be554aa42c92380e rdf:first sg:person.010264243767.07
177 rdf:rest N4d12dce4fa57406d92b93455efaafa40
178 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
179 schema:name Medical and Health Sciences
180 rdf:type schema:DefinedTerm
181 anzsrc-for:1101 schema:inDefinedTermSet anzsrc-for:
182 schema:name Medical Biochemistry and Metabolomics
183 rdf:type schema:DefinedTerm
184 sg:grant.7190343 http://pending.schema.org/fundedItem sg:pub.10.1186/s12944-019-0971-1
185 rdf:type schema:MonetaryGrant
186 sg:grant.8368373 http://pending.schema.org/fundedItem sg:pub.10.1186/s12944-019-0971-1
187 rdf:type schema:MonetaryGrant
188 sg:journal.1031029 schema:issn 1476-511X
189 schema:name Lipids in Health and Disease
190 schema:publisher Springer Nature
191 rdf:type schema:Periodical
192 sg:person.010264243767.07 schema:affiliation grid-institutes:grid.268079.2
193 schema:familyName Hu
194 schema:givenName Shumei
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010264243767.07
196 rdf:type schema:Person
197 sg:person.01053105430.44 schema:affiliation grid-institutes:None
198 schema:familyName Guo
199 schema:givenName Shoudong
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053105430.44
201 rdf:type schema:Person
202 sg:person.010676021371.03 schema:affiliation grid-institutes:None
203 schema:familyName Zhou
204 schema:givenName Guanghai
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010676021371.03
206 rdf:type schema:Person
207 sg:person.011657204767.66 schema:affiliation grid-institutes:grid.268079.2
208 schema:familyName Wang
209 schema:givenName Jin
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011657204767.66
211 rdf:type schema:Person
212 sg:person.013252145767.19 schema:affiliation grid-institutes:grid.268079.2
213 schema:familyName Yang
214 schema:givenName Zixun
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013252145767.19
216 rdf:type schema:Person
217 sg:person.014645106767.17 schema:affiliation grid-institutes:grid.268079.2
218 schema:familyName Yin
219 schema:givenName Jiayu
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014645106767.17
221 rdf:type schema:Person
222 sg:person.016074614653.96 schema:affiliation grid-institutes:grid.268079.2
223 schema:familyName Hou
224 schema:givenName Pengbo
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016074614653.96
226 rdf:type schema:Person
227 sg:pub.10.1038/nm.1956 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013401823
228 https://doi.org/10.1038/nm.1956
229 rdf:type schema:CreativeWork
230 sg:pub.10.1038/nrcardio.2010.222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003407437
231 https://doi.org/10.1038/nrcardio.2010.222
232 rdf:type schema:CreativeWork
233 sg:pub.10.1186/s12944-016-0393-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040094135
234 https://doi.org/10.1186/s12944-016-0393-2
235 rdf:type schema:CreativeWork
236 grid-institutes:None schema:alternateName Taishan Medical University, Taian, 271000 China
237 schema:name Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China
238 Research Center on Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin, 150076 China
239 Taishan Medical University, Taian, 271000 China
240 rdf:type schema:Organization
241 grid-institutes:grid.268079.2 schema:alternateName Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China
242 schema:name Institute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Weifang Medical University, 7166# Baotongxi Street, Weifang, 261053 Shandong Province China
243 Research Center on Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin, 150076 China
244 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...